Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Emerging SARS-CoV-2 variants: impact on vaccine efficacy and neutralizing antibodies
Khan Sharun, Ruchı Tıwarı, Kuldeep Dhama, et al.
Human Vaccines & Immunotherapeutics (2021) Vol. 17, Iss. 10, pp. 3491-3494
Open Access | Times Cited: 46

Showing 1-25 of 46 citing articles:

Global emerging Omicron variant of SARS-CoV-2: Impacts, challenges and strategies
Kuldeep Dhama, Firzan Nainu, Andri Frediansyah, et al.
Journal of Infection and Public Health (2022) Vol. 16, Iss. 1, pp. 4-14
Open Access | Times Cited: 199
Mutations of SARS-CoV-2 spike protein: Implications on immune evasion and vaccine-induced immunity
Hylemariam Mihiretie Mengist, Arnaud John Kombe Kombe, Daniel Mekonnen, et al.
Seminars in Immunology (2021) Vol. 55, pp. 101533-101533
Open Access | Times Cited: 105
Omicron variant (B.1.1.529) and its sublineages: What do we know so far amid the emergence of recombinant variants of SARS-CoV-2?
Manish Dhawan, AbdulRahman A. Saied, Saikat Mitra, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 154, pp. 113522-113522
Open Access | Times Cited: 93
Delta variant (B.1.617.2) of SARS-CoV-2: Mutations, impact, challenges and possible solutions
Manish Dhawan, Abhilasha Sharma, Priyanka Choudhary, et al.
Human Vaccines & Immunotherapeutics (2022) Vol. 18, Iss. 5
Open Access | Times Cited: 87
COVID-19 intranasal vaccines: current progress, advantages, prospects, and challenges
Kuldeep Dhama, Manish Dhawan, Ruchi Tiwari, et al.
Human Vaccines & Immunotherapeutics (2022) Vol. 18, Iss. 5
Open Access | Times Cited: 75
Safety & effectiveness of COVID-19 vaccines: A narrative review
Francesco Chirico, Jaime A. Teixeira da Silva, Panagiotis Tsigaris, et al.
The Indian Journal of Medical Research (2022) Vol. 155, Iss. 1, pp. 91-104
Open Access | Times Cited: 54
Natural Bioactive Molecules: An Alternative Approach to the Treatment and Control of COVID-19
Fahadul Islam, Shabana Bibi, Atkia Farzana Khan Meem, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 23, pp. 12638-12638
Open Access | Times Cited: 50
D614G mutation and SARS-CoV-2: impact on S-protein structure, function, infectivity, and immunity
Manojit Bhattacharya, Srijan Chatterjee, Ashish Ranjan Sharma, et al.
Applied Microbiology and Biotechnology (2021) Vol. 105, Iss. 24, pp. 9035-9045
Open Access | Times Cited: 47
Interactions of the Receptor Binding Domain of SARS-CoV-2 Variants with hACE2: Insights from Molecular Docking Analysis and Molecular Dynamic Simulation
İsmail Çeli̇k, Rohitash Yadav, Zekeriya Düzgün, et al.
Biology (2021) Vol. 10, Iss. 9, pp. 880-880
Open Access | Times Cited: 44
Association of total and neutralizing SARS-CoV-2 spike -receptor binding domain antibodies with epidemiological and clinical characteristics after immunization with the 1st and 2nd doses of the BNT162b2 vaccine
Athanasios Michos, Elizabeth‐Barbara Tatsi, Filippos Filippatos, et al.
Vaccine (2021) Vol. 39, Iss. 40, pp. 5963-5967
Open Access | Times Cited: 41
Casirivimab and Imdevimab for the Treatment of Hospitalized Patients With COVID-19
Selin Somersan-Karakaya, Eleftherios Mylonakis, Vidya Menon, et al.
The Journal of Infectious Diseases (2022) Vol. 227, Iss. 1, pp. 23-34
Open Access | Times Cited: 33
A Five-Helix-Based SARS-CoV-2 Fusion Inhibitor Targeting Heptad Repeat 2 Domain against SARS-CoV-2 and Its Variants of Concern
Lixiao Xing, Xinfeng Xu, Wei Xu, et al.
Viruses (2022) Vol. 14, Iss. 3, pp. 597-597
Open Access | Times Cited: 32
Seroprevalence against SARS-CoV-2 after booster vaccination in a prison in Alicante (Spain)
A.C. Montagud, Raúl Moragues, Nancy Vicente-Alcalde, et al.
Frontiers in Public Health (2025) Vol. 13
Open Access
Recombinant protein HR212 targeting heptad repeat 2 domain in spike protein S2 subunit elicits broad‐spectrum neutralizing antibodies against SARS‐CoV‐2 and its variants
Ying Lu, An‐Qi Li, Fan Shen, et al.
MedComm (2025) Vol. 6, Iss. 2
Open Access
COVID-19 vaccination passport: prospects, scientific feasibility, and ethical concerns
Khan Sharun, Ruchı Tıwarı, Kuldeep Dhama, et al.
Human Vaccines & Immunotherapeutics (2021) Vol. 17, Iss. 11, pp. 4108-4111
Open Access | Times Cited: 37
Reduced sensitivity of the SARS-CoV-2 Lambda variant to monoclonal antibodies and neutralizing antibodies induced by infection and vaccination
Meiyu Wang, Li Zhang, Qianqian Li, et al.
Emerging Microbes & Infections (2021) Vol. 11, Iss. 1, pp. 18-29
Open Access | Times Cited: 34
SARS-CoV-2 vaccine for domestic and captive animals: An effort to counter COVID-19 pandemic at the human-animal interface
Khan Sharun, Ruchi Tiwari, AbdulRahman A. Saied, et al.
Vaccine (2021) Vol. 39, Iss. 49, pp. 7119-7122
Open Access | Times Cited: 33
Bovine-derived antibodies and camelid-derived nanobodies as biotherapeutic weapons against SARS-CoV-2 and its variants: A review article
AbdulRahman A. Saied, Asmaa A. Metwally, Moses Alobo, et al.
International Journal of Surgery (2022) Vol. 98, pp. 106233-106233
Open Access | Times Cited: 23
Fruit Bromelain-Derived Peptide Potentially Restrains the Attachment of SARS-CoV-2 Variants to hACE2: A Pharmacoinformatics Approach
Trina Ekawati Tallei, Fatimawali Fatimawali, Ahmad Akroman Adam, et al.
Molecules (2022) Vol. 27, Iss. 1, pp. 260-260
Open Access | Times Cited: 22
Can the SARS-CoV-2 Omicron Variant Confer Natural Immunity against COVID-19?
Abdul Hawil Abas, Siti Marfuah, Rinaldi Idroes, et al.
Molecules (2022) Vol. 27, Iss. 7, pp. 2221-2221
Open Access | Times Cited: 19
Role of Vitamin D as Protective Agent against Induced Liver Damage in Male Rats.
M K Hassani
DOAJ (DOAJ: Directory of Open Access Journals) (2021) Vol. 76, Iss. 6, pp. 1815-1822
Closed Access | Times Cited: 23
Comparative overview of emerging RNA viruses: Epidemiology, pathogenesis, diagnosis and current treatment
Ishani Chakrabartty, Maryam Khan, Saurov Mahanta, et al.
Annals of Medicine and Surgery (2022) Vol. 79
Open Access | Times Cited: 17
Modern drug discovery applications for the identification of novel candidates for COVID-19 infections
Isha Rani, Avjit Kalsi, Gagandeep Kaur, et al.
Annals of Medicine and Surgery (2022) Vol. 80
Open Access | Times Cited: 16
The Main Protease of SARS-CoV-2 as a Target for Phytochemicals against Coronavirus
Shaza S. Issa, С. В. Сокорнова, Roman R. Zhidkin, et al.
Plants (2022) Vol. 11, Iss. 14, pp. 1862-1862
Open Access | Times Cited: 15
Variation in synonymous evolutionary rates in the SARS-CoV-2 genome
Qianru Sun, Jinfeng Zeng, Kang Tang, et al.
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 8
Page 1 - Next Page

Scroll to top